VenoStent is a San Francisco-based medical device startup that develops a specialized wrap designed to improve the outcomes of dialysis and bypass surgeries. The device is applied around blood vessels during surgery to prevent vessel failure. The company utilizes 3D printing technology to create its products and is currently in the launched stage.
VenoStent was founded by the VenoStent Team. The company is part of the Y Combinator ecosystem and is currently operating as a full-time, remote-friendly venture based out of San Francisco, California.
VenoStent addresses the high failure rate associated with dialysis and bypass surgeries. Statistics show that out of 10 million such surgeries performed annually, approximately half fail. VenoStent’s vascular wrap technology aims to lower these failure rates and save lives by providing structural support to vessels during the surgical process.
VenoStent works by providing a physical wrap that is placed around blood vessels during vascular surgeries. This wrap is designed to reinforce the vessels and prevent the complications that typically lead to surgery failure. The company leverages 3D printing as a core skill in the development of these medical devices.
VenoStent is located in San Francisco, California. The company maintains a remote-friendly work environment and focuses on the medical device industry.
VenoStent falls under the Medical Devices category, specifically focusing on vascular surgery support. Its core competencies include 3D printing and medical device engineering aimed at dialysis and bypass surgery patients.